Developer docs
API playgroundTry for free, no card

Search company profiles

Magellan Rx Management

Full company profile

uuid000g2nz

Namestring
Magellan Rx Management
Legal namestring
Magellan RX Management
Company typeenum
Private
Founded yearint
2014
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersPhoenix, United States
HQ citystring
Phoenix
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical vendor analysis, peptide comparison service, drug pricing transparency, supplier evaluation platform, pharmaceutical market research
Industry3 codes
1Amino Acids & Peptides (BCAAs, Collagen Peptides, Bioactive Peptides, L-Theanine)
CodeAFAJAKAGPrimaryYes
2Protein Hydrolysates & Peptides (Enzymatic Hydrolysates, Bioactive Peptides)
CodeAFAJAHAIPrimaryNo
3Therapeutic Peptides & Protein/Peptide Biologics
CodeHLAAAAAHPrimaryNo
NAICS code2 codes
  • Marketing Research and Public Opinion Polling541910
  • Advertising Agencies541810
Product category
Pharmaceutical Vendor Comparison
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Affiliate Marketing
TypeAffiliate Referral
Description

Magellan RX Management participates in affiliate marketing programs where they earn commissions when users click affiliate links and make purchases from referenced peptide vendors. There is no additional cost to users. The company maintains editorial independence and does not accept payment in exchange for favorable reviews or rankings.

www1.magellanrx.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Marketing or Sales, Operations
GTM typeB2C
B2C
Offering typeDigital Commerce or Conte…
Digital Commerce or Content
Core offering1 text field

Independent research and analysis platform that ranks US peptide vendors based on cost optimization, product quality, and operational reliability. Provides vendor comparison content covering retatrutide, BPC-157, GHK-Cu, Klow Stack, Glow Stack, Ipamorelin, Wolverine Stack, KPV, and Sermorelin peptides, plus muscle growth peptide rankings. Revenue is generated through affiliate marketing commissions while maintaining editorial independence from vendor influence.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Magellan Rx Management is an independent research and analysis platform (not a product seller) that provides transparent vendor comparisons for the research peptide marketplace. The platform offers a portfolio of comparison services covering various peptide types including Retatrutide, BPC-157, GHK-Cu, Klow Stack, Glow Stack, Ipamorelin, Wolverine Stack (BPC-157 + TB-500), KPV, and Sermorelin, along with muscle growth peptide rankings. Each comparison service evaluates US peptide vendors based on cost optimization, product quality, and operational reliability, helping researchers identify quality-focused suppliers that meet higher standards of quality, consistency, and verification.

Product and service1 record
1Peptide Vendor Comparison Service
CategoryComparison Service
Description

Independent vendor comparison and ranking service evaluating US peptide suppliers based on cost optimization, product quality, and operational reliability. Covers comparisons for retatrutide, BPC-157, GHK-Cu, Klow Stack, Glow Stack, Ipamorelin, Wolverine Stack (BPC-157 + TB-500), KPV, and Sermorelin peptides, plus muscle growth peptide rankings. Designed for researchers and laboratory professionals seeking transparent vendor information for the research peptide marketplace.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeOthers
Description

While a health platform rather than a comparison site, Noom illustrates the consumer health affiliate/content economics at scale. Useful adjacent reference for understanding affiliate-driven health content monetization that Magellan Rx Management operates within.

TypeBroad incumbent
Description

Prescription drug price-comparison and discount platform earning affiliate revenue via pharmacy referrals. Comparable to Magellan Rx Management in applying comparison content + referral monetization to pharmaceutical purchasing decisions, though at much larger scale and across approved drugs rather than research peptides.

TypeBroad incumbent
Description

Large-scale drug price comparison and coupon platform. Magellan Rx Management operates a structurally similar content + affiliate model but scoped narrowly to research peptides, mirroring GoodRx's playbook of monetizing prescription price transparency through referral economics.

TypeEmerging player
Description

Independent product review and comparison site for health and wellness services including telehealth and supplements. Uses similar SEO-driven content + affiliate monetization, covering some peptide-adjacent categories like hormone therapy and nootropics.

TypeDirect peer
Description

Independent price-comparison platform for medications with a verification/accreditation layer. The closest direct analog: an 'independent' comparison site that ranks pharmacy suppliers on price, legitimacy, and reputation and monetizes via referrals - essentially the same GTM motion as Magellan Rx Management applied to peptides.

TypeBroad incumbent
Description

Drug price comparison and coupon site with affiliate referral economics. Shares the same 'informational comparison → referral' revenue architecture as Magellan Rx Management's peptide-vendor model.

TypeDirect peer
Description

Independent research and analysis platform covering supplements and compounds with editorial integrity as a core differentiator. Comparable to Magellan Rx Management in positioning itself as an unbiased, evidence-led resource for non-mainstream compounds, monetized through affiliate and content channels.

TypeDirect peer
Description

Third-party testing and ranking platform for supplements using lab-verified quality data. Magellan Rx Management uses a comparable methodology (testing transparency, quality signals, third-party reputation) to rank peptide vendors, applying Labdoor's supplement-evaluation playbook to the peptide category.

TypeBroad incumbent
Description

Large-scale consumer health information publisher monetized through affiliate and content partnerships. Comparable SEO-led, content-monetization model with editorial positioning, though at vastly greater scale and breadth than Magellan Rx Management's peptide-niche focus.

TypeOthers
Description

A peptide vendor ranked on Magellan Rx Management's platform. Not a direct competitor but a supply-side counterparty and observable signal of the peptide merchant ecosystem that Magellan Rx Management monetizes through affiliate links.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Magellan Rx Management

Pharmaceutical Vendor Comparisonwww1.magellanrx.com

Magellan Rx Management firmographics

Firmographics
Name
Magellan Rx Management
Legal name
Magellan RX Management
Website
https://www1.magellanrx.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
1,001–5,000 employees
Ownership category
akta.pro rank

Magellan Rx Management industry classification

Industry
Product category
Pharmaceutical Vendor Comparison
NAICS
Marketing Research and Public Opinion Polling (541910), Advertising Agencies (541810)
akta.pro primary industry
Amino Acids & Peptides (BCAAs, Collagen Peptides, Bioactive Peptides, L-Theanine) (AFAJAKAG)
akta.pro secondary industries
Protein Hydrolysates & Peptides (Enzymatic Hydrolysates, Bioactive Peptides) (AFAJAHAI), Therapeutic Peptides & Protein/Peptide Biologics (HLAAAAAH)

Keywords

  • Pharmaceutical vendor analysis
  • Peptide comparison service
  • Drug pricing transparency
  • Supplier evaluation platform
  • Pharmaceutical market research

Where Magellan Rx Management is headquartered

Location

Headquarters

HQ city
Phoenix
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Magellan Rx Management business model

Business model
GTM type
B2C
Offering type
Digital Commerce or Content
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. Affiliate Marketing: Magellan RX Management participates in affiliate marketing programs where they earn commissions when users click affiliate links and make purchases from referenced peptide vendors. There is no additional cost to users. The company maintains editorial independence and does not accept payment in exchange for favorable reviews or rankings.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Magellan Rx Management product offering

Product offering

Core offering

Independent research and analysis platform that ranks US peptide vendors based on cost optimization, product quality, and operational reliability. Provides vendor comparison content covering retatrutide, BPC-157, GHK-Cu, Klow Stack, Glow Stack, Ipamorelin, Wolverine Stack, KPV, and Sermorelin peptides, plus muscle growth peptide rankings. Revenue is generated through affiliate marketing commissions while maintaining editorial independence from vendor influence.

Product overview

Magellan Rx Management is an independent research and analysis platform (not a product seller) that provides transparent vendor comparisons for the research peptide marketplace. The platform offers a portfolio of comparison services covering various peptide types including Retatrutide, BPC-157, GHK-Cu, Klow Stack, Glow Stack, Ipamorelin, Wolverine Stack (BPC-157 + TB-500), KPV, and Sermorelin, along with muscle growth peptide rankings. Each comparison service evaluates US peptide vendors based on cost optimization, product quality, and operational reliability, helping researchers identify quality-focused suppliers that meet higher standards of quality, consistency, and verification.

Differentiator

Problem solved

Functional benefit

Products and services

  • Peptide Vendor Comparison Service Independent vendor comparison and ranking service evaluating US peptide suppliers based on cost optimization, product quality, and operational reliability. Covers comparisons for retatrutide, BPC-157, GHK-Cu, Klow Stack, Glow Stack, Ipamorelin, Wolverine Stack (BPC-157 + TB-500), KPV, and Sermorelin peptides, plus muscle growth peptide rankings. Designed for researchers and laboratory professionals seeking transparent vendor information for the research peptide marketplace.

Companies that use Magellan Rx Management

Customer profile

Segments2 records

Ideal customer profiles2 records

Magellan Rx Management technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Magellan Rx Management partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves5 records

Expansion highlights3 records

Magellan Rx Management competitors and assessment

Company assessment

Others

  • Noom (content/health affiliate): While a health platform rather than a comparison site, Noom illustrates the consumer health affiliate/content economics at scale. Useful adjacent reference for understanding affiliate-driven health content monetization that Magellan Rx Management operates within.
  • Peptide Sciences: A peptide vendor ranked on Magellan Rx Management's platform. Not a direct competitor but a supply-side counterparty and observable signal of the peptide merchant ecosystem that Magellan Rx Management monetizes through affiliate links.

Broad incumbents

  • SingleCare: Prescription drug price-comparison and discount platform earning affiliate revenue via pharmacy referrals. Comparable to Magellan Rx Management in applying comparison content + referral monetization to pharmaceutical purchasing decisions, though at much larger scale and across approved drugs rather than research peptides.
  • GoodRx: Large-scale drug price comparison and coupon platform. Magellan Rx Management operates a structurally similar content + affiliate model but scoped narrowly to research peptides, mirroring GoodRx's playbook of monetizing prescription price transparency through referral economics.
  • RxSaver: Drug price comparison and coupon site with affiliate referral economics. Shares the same 'informational comparison → referral' revenue architecture as Magellan Rx Management's peptide-vendor model.
  • Healthline Media: Large-scale consumer health information publisher monetized through affiliate and content partnerships. Comparable SEO-led, content-monetization model with editorial positioning, though at vastly greater scale and breadth than Magellan Rx Management's peptide-niche focus.

Emerging players

  • Innerbody Research: Independent product review and comparison site for health and wellness services including telehealth and supplements. Uses similar SEO-driven content + affiliate monetization, covering some peptide-adjacent categories like hormone therapy and nootropics.

Direct peers

  • PharmacyChecker: Independent price-comparison platform for medications with a verification/accreditation layer. The closest direct analog: an 'independent' comparison site that ranks pharmacy suppliers on price, legitimacy, and reputation and monetizes via referrals - essentially the same GTM motion as Magellan Rx Management applied to peptides.
  • Examine.com: Independent research and analysis platform covering supplements and compounds with editorial integrity as a core differentiator. Comparable to Magellan Rx Management in positioning itself as an unbiased, evidence-led resource for non-mainstream compounds, monetized through affiliate and content channels.
  • Labdoor: Third-party testing and ranking platform for supplements using lab-verified quality data. Magellan Rx Management uses a comparable methodology (testing transparency, quality signals, third-party reputation) to rank peptide vendors, applying Labdoor's supplement-evaluation playbook to the peptide category.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights5 records

Customer concentration

Magellan Rx Management social profiles

Digital presence

Magellan Rx Management financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Magellan Rx Management leadership team

Management profile

Number of profiles

Profiles1 record

Magellan Rx Management funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Magellan Rx Management M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Magellan Rx Management

What does Magellan Rx Management do?

Independent research and analysis platform that ranks US peptide vendors based on cost optimization, product quality, and operational reliability. Provides vendor comparison content covering retatrutide, BPC-157, GHK-Cu, Klow Stack, Glow Stack, Ipamorelin, Wolverine Stack, KPV, and Sermorelin peptides, plus muscle growth peptide rankings. Revenue is generated through affiliate marketing commissions while maintaining editorial independence from vendor influence.

Is Magellan Rx Management a public or private company?

Magellan Rx Management is a private company. It is classified as unknown and is currently operating.

When was Magellan Rx Management founded?

Magellan Rx Management was founded in 2014. It employs 1,001 to 5,000 people.

Where is Magellan Rx Management based?

Magellan Rx Management is headquartered in Phoenix, United States, in the North America region.

How does Magellan Rx Management make money?

One revenue line is on record: affiliate Marketing.

Who are Magellan Rx Management's main competitors?

Others on record are Noom (content/health affiliate) and Peptide Sciences. Broad incumbents are SingleCare, GoodRx, RxSaver and Healthline Media. Innerbody Research is listed as an emerging player. Direct peers are PharmacyChecker, Examine.com and Labdoor.

Does Magellan Rx Management have an API?

No public API is recorded for Magellan Rx Management.

What industry is Magellan Rx Management in?

Magellan Rx Management's product category is Pharmaceutical Vendor Comparison. Its primary akta.pro industry code is AFAJAKAG, Amino Acids & Peptides (BCAAs, Collagen Peptides, Bioactive Peptides, L-Theanine), with a secondary code of AFAJAHAI, Protein Hydrolysates & Peptides (Enzymatic Hydrolysates, Bioactive Peptides). Its NAICS code is 541910.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
St. Louis AmericanPrime/MRx’s new Pharmacy Match technology-driven solution expands specialty pharmacy access and choicePrime Therapeutics LLC and Magellan Rx Management (collectively Prime/MRx) launched Pharmacy Match, a technology-enabled specialty pharmacy solution designed to expand access and lower drug costs for plan sponsors through real-time pricing and an expanded specialty pharmacy network. The solution is powered by Free Market Health's cloud-based technology platform, which tracks specialty claims from referral to fulfillment and enables comparison shopping across pharmacies. Prime/MRx stated that Pharmacy Match represents its first step toward an intelligently designed, technology-enabled specialty care model that improves the member experience while driving savings and reducing waste.PR NewswirePrime/MRx's new Pharmacy Match technology-driven solution expands specialty pharmacy access and choicePrime Therapeutics LLC and Magellan Rx Management launched Pharmacy Match on June 19, 2024, a technology-enabled specialty pharmacy solution designed to expand member access to specialty medications while lowering drug costs for plan sponsors. The solution, powered by Free Market Health's cloud-based technology platform, uses real-time pricing and referral comparison to direct members to the most competitive specialty pharmacy suited to their needs. The companies cite specialty drugs as the fastest-growing area of pharmacy spend, accounting for more than half of the pharmaceutical market, as the driver behind this initiative to address fragmentation and affordability challenges in the specialty pharmacy space.PR NewswireMagellan Medicaid Administration Achieves ISO 9001:2015 RecertificationPrime Therapeutics LLC and Magellan Rx announced that Magellan Medicaid Administration has earned ISO 9001:2015 recertification for its pharmacy benefit administration services for state government contracts. The recertification recognizes MMA's quality management systems focused on continuous improvement and customer satisfaction, with the company servicing programs in 28 states and the District of Columbia. MMA, with over 39 years of PBA experience, positions itself as an industry leader in Medicaid pharmacy programs delivering value-based solutions to state partners.PR NewswirePrime/Magellan Rx launch industry-leading Medical Pharmacy Trend Report™Prime Therapeutics LLC and Magellan Rx Management LLC released their 13th annual Medical Pharmacy Trend Report, providing comprehensive analysis of medical benefit drug trends across commercial, Medicare, and Medicaid programs. The report found that Commercial saw a 13.5% year-over-year spend trend driven by increased utilization, while oncology remains the top trend driver with Keytruda climbing 58% in per-member-per-month spend in Commercial. Oncology biosimilars are capturing over 75% of the market across all lines of business, with the report noting that payer concerns centered on gene and cell therapies and oncology as top spending concerns.PR NewswirePrime Therapeutics and Magellan Rx enhance specialty pharmacy patient experience with Inovalon's ScriptMed® SaaS SolutionPrime Therapeutics and its subsidiary Magellan Rx Pharmacy have entered into a multi-year agreement with Inovalon to implement the ScriptMed® Cloud platform. This partnership aims to enhance patient support and digital engagement for specialty pharmacy patients by leveraging data-driven, cloud-based solutions. The implementation is designed to streamline operations, reduce waste, and improve access to therapy for members on specialty medications.PR NewswireMagellan Rx Management releases new report, "The State of Value-based Contracting (VBC): Reinventing the Current Drug Payment Model in Medicaid"Magellan Rx Management published a new Medicaid Pharmacy Insights report examining how state Medicaid programs can manage the financial burden of expensive cell and gene therapies, which can cost $500,000 to over $1 million per treatment. The report introduces Value Plus, described as the first multi-state value-based contracting solution designed to help state Medicaid programs negotiate pricing linked to patient health outcomes. The solution aims to mitigate financial risk for states by requiring manufacturers to provide refunds if predetermined outcome metrics are not achieved, while helping ensure patient access to potentially curative therapies.PR NewswireMostafa Kamal to succeed Ken Paulus as Prime Therapeutics' President and Chief Executive OfficerPrime Therapeutics LLC announced that Mostafa Kamal will succeed Ken Paulus as President and Chief Executive Officer, with Paulus retiring after four years leading the pharmacy benefit manager. Kamal, who currently serves as president of Prime Therapeutics and CEO of Magellan Rx, played a key role in the 2022 agreement that combined Prime and Magellan Rx into a unified organization serving nearly 38 million members. The transition positions the company to pursue its vision of reshaping pharmacy benefit management under new leadership.PR NewswireMagellan Rx Management earns reaccreditation from the National Committee for Quality AssuranceMagellan Rx Management, LLC announced it was reaccredited by the National Committee for Quality Assurance (NCQA) for Utilization Management Accreditation. The accreditation focuses on consumer protection and service improvement, confirming that Magellan Rx has the systems, processes, and personnel in place to conduct utilization management according to NCQA quality standards. NCQA's review covered Magellan Rx Management's Utilization Management functions only.PR NewswireMagellan Rx Management issues seventh Medicaid Pharmacy Trend Report™Magellan Rx Management, a Prime Therapeutics LLC company, released its seventh annual Medicaid Pharmacy Trend Report detailing trends in the Medicaid pharmacy fee-for-service space. The report tracks top drug classes by spend and ranks the top 50 classes by percent of net spend, comparing 2020 to 2021 data drawn from Medicaid FFS pharmacy programs in 24 states and the District of Columbia. The report notes that states will increasingly focus on paying for curative therapies, high-cost drugs, and addressing the opioid epidemic and mental health resource challenges.PR NewswireMedical Pharmacy Trend Report™ delivers insights, forecasting in 12th editionMagellan Rx Management, a Prime Therapeutics LLC company, released its 12th annual Medical Pharmacy Trend Report on December 14, 2022, providing comprehensive analysis of provider-administered medical benefit drug trends across Commercial, Medicare, and Medicaid markets. The report found that oncology remained the top spend category, accounting for 39% of Commercial, 53% of Medicare, and 27% of Medicaid spend, while oncology biosimilars contributed to an estimated 7% reduction in oncology per member per month spend for Commercial markets since 2019. The forecast predicts medical drug spend will increase over the next three years, driven primarily by oncology and high-cost novel molecular entities in the rare disease category.